Corrigendum: STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer (Oncogene (2014) 34 (4808-4820) DOI: 10.1038/onc.2014.404);STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer

Oncogene

Volumn 34, Issue 37, 2015, Pages 4808-4820

  Zhang, Z ^a   Liu, X ^a   Feng, B ^a   Liu, N ^a   Wu, Q ^a   Han, Y ^a   Nie, Y ^a   Wu, K ^a   Shi, Y ^a   Fan, D ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CALCIUM; FIBRONECTIN; MESSENGER RNA; MICRORNA; MICRORNA 185; STROMAL INTERACTION MOLECULE 1; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; MEMBRANE PROTEIN; MIRN185 MICRORNA, HUMAN; STIM1 PROTEIN, HUMAN; TUMOR PROTEIN;

3' UNTRANSLATED REGION; ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CANCER GROWTH; CANCER MORPHOLOGY; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL JUNCTION; CELL MIGRATION; COLORECTAL CANCER; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; RNA PROCESSING; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; AGED; CELL CULTURE; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION; GENETICS; HT 29 CELL LINE; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CELLS, CULTURED; COLORECTAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; MALE; MEMBRANE PROTEINS; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROGNOSIS;

EID: 84941314864     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2016.140     Document Type: Erratum

References (51)

1. Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009; 59: 366-378.
2. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 2009; 361: 2449-2460.
3. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
4. Christofori G. New signals from the invasive front. Nature 2006; 441: 444-450.
5. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-130.
6. Zhao L, Wang H, Liu C, Liu Y, Wang X, Wang S et al. Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1. Gut 2010; 59: 1226-1235.
7. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003; 4: 517-529.
8. Parekh AB. Store-operated CRAC channels: function in health and disease. Nat Rev Drug Discov 2010; 9: 399-410.
9. Putney JW Jr. Capacitative calcium entry: sensing the calcium stores. J Cell Biol 2005; 169: 381-382.
10. Zhang SL, Yu Y, Roos J, Kozak JA, Deerinck TJ, Ellisman MH et al. STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane. Nature 2005; 437: 902-905.
11. Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 2006; 441: 179-185.
12. Zhang SL, Yeromin AV, Zhang XH, Yu Y, Safrina O, Penna A et al. Genome-wide RNAi screen of Ca(2+) influx identifies genes that regulate Ca(2+) releaseactivated Ca(2+) channel activity. Proc Natl Acad Sci USA 2006; 103: 9357-9362.
13. Park CY, Hoover PJ, Mullins FM, Bachhawat P, Covington ED, Raunser S et al. STIM1 clusters and activates CRAC channels via direct binding of a cytosolic domain to Orai1. Cell 2009; 136: 876-890.
14. Lioudyno MI, Kozak JA, Penna A, Safrina O, Zhang SL, Sen D et al. Orai1 and STIM1 move to the immunological synapse and are up-regulated during T cell activation. Proc Natl Acad Sci USA 2008; 105: 2011-2016.
15. Guo RW, Wang H, Gao P, Li MQ, Zeng CY, Yu Y et al. An essential role for stromal interaction molecule 1 in neointima formation following arterial injury. Cardiovasc Res 2009; 81: 660-668.
16. Varga-Szabo D, Braun A, Kleinschnitz C, Bender M, Pleines I, Pham M et al. The calcium sensor STIM1 is an essential mediator of arterial thrombosis and ischemic brain infarction. J Exp Med 2008; 205: 1583-1591.
17. Okabe H, Hale TM, Kumon H, Heaton JP, Adams MA. The penis is not protected-in hypertension there are vascular changes in the penis which are similar to those in other vascular beds. Int J Impot Res 1999; 11: 133-140.
18. Lu W, Wang J, Peng G, Shimoda LA, Sylvester JT. Knockdown of stromal interaction molecule 1 attenuates store-operated Ca2+ entry and Ca2+ responses to acute hypoxia in pulmonary arterial smooth muscle. Am J Physiol Lung Cell Mol Physiol 2009; 297: L17-L25.
19. Suyama E, Wadhwa R, Kaur K, Miyagishi M, Kaul SC, Kawasaki H et al. Identification of metastasis-related genes in a mouse model using a library of randomized ribozymes. J Biol Chem 2004; 279: 38083-38086.
20. Roberts-Thomson SJ, Peters AA, Grice DM, Monteith GR. ORAI-mediated calcium entry: mechanism and roles, diseases and pharmacology. Pharmacol Ther 2010; 127: 121-130.
21. Yang S, Zhang JJ, Huang XY. Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 2009; 15: 124-134.
22. Chen YF, Chiu WT, Chen YT, Lin PY, Huang HJ, Chou CY et al. Calcium store sensor stromal-interaction molecule 1-dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesis. Proc Natl Acad Sci USA 2011; 108: 15225-15230.
23. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
24. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-142.
25. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593-601.
26. Kraljevic Pavelic S, Sedic M, Bosnjak H, Spaventi S, Pavelic K. Metastasis: new perspectives on an old problem. Mol Cancer 2011; 10: 22.
27. Loboda A, Nebozhyn MV, Watters JW, Buser CA, Shaw PM, Huang PS et al. EMT is the dominant program in human colon cancer. BMC Med Genom 2011; 4: 9.
28. Gulhati P, Bowen KA, Liu J, Stevens PD, Rychahou PG, Chen M et al. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res 2011; 71: 3246-3256.
29. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7: 415-428.
30. Hu J, Qin K, Zhang Y, Gong J, Li N, Lv D et al. Downregulation of transcription factor Oct4 induces an epithelial-to-mesenchymal transition via enhancement of Ca2+ influx in breast cancer cells. Biochem Biophys Res Commun 2011; 411: 786-791.
31. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
32. Zhang H, Li Y, Lai M. The microRNA network and tumor metastasis. Oncogene 2010; 29: 937-948.
33. Gregory PA, Bracken CP, Bert AG, Goodall GJ. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell cycle 2008; 7: 3112-3118.
34. Wang Z, Li Y, Ahmad A, Azmi AS, Kong D, Banerjee S et al. Targeting miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance. Drug Resist Updates 2010; 13: 109-118.
35. Zhuang R, Rao JN, Zou T, Liu L, Xiao L, Cao S et al. miR-195 competes with HuR to modulate stim1 mRNA stability and regulate cell migration. Nucleic Acids Res 2013; 41: 7905-7919.
36. Liu X, Zhang Z, Sun L, Chai N, Tang S, Jin J et al. MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4. Carcinogenesis 2011; 32: 1798-1805.
37. Duranton B, Holl V, Schneider Y, Carnesecchi S, Gosse F, Raul F et al. Polyamine metabolism in primary human colon adenocarcinoma cells (SW480) and their lymph node metastatic derivatives (SW620). Amino acids 2003; 24: 63-72.
38. Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010; 29: 4741-4751.
39. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2014; 15: 178-196.
40. Prevarskaya N, Skryma R, Shuba Y. Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer 2011; 11: 609-618.
41. Yang S, Huang XY. Ca2+ influx through L-type Ca2+ channels controls the trailing tail contraction in growth factor-induced fibroblast cell migration. J Biol Chem 2005; 280: 27130-27137.
42. Ritchie MF, Zhou Y, Soboloff J. WT1/EGR1-mediated control of STIM1 expression and function in cancer cells. Front Biosci 2011; 16: 2402-2415.
43. Stanisz H, Saul S, Muller CS, Kappl R, Niemeyer BA, Vogt T et al. Inverse regulation of melanoma growth and migration by Orai1/STIM2-dependent calcium entry. Pigment Cell Melanoma Res 2014; 27: 442-453.
44. Tan Z, Jiang H, Wu Y, Xie L, Dai W, Tang H et al. miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer. Mol Cell Biochem 2014; 386: 223-231.
45. Zhi Q, Zhu J, Guo X, He S, Xue X, Zhou J et al. Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage. Biomed Pharmacother 2013; 67: 393-398.
46. Takahashi Y, Forrest AR, Maeno E, Hashimoto T, Daub CO, Yasuda J. MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS One 2009; 4: e6677.
47. Liu M, Lang N, Chen X, Tang Q, Liu S, Huang J et al. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells. Cancer Lett 2011; 301: 151-160.
48. Tang H, Wang Z, Liu X, Liu Q, Xu G, Li G et al. LRRC4 inhibits glioma cell growth and invasion through a miR-185-dependent pathway. Curr Cancer Drug Targets 2012; 12: 1032-1042.
49. Yoon JH, Choi YJ, Choi WS, Ashktorab H, Smoot DT, Nam SW et al. GKN1-miR-185-DNMT1 axis suppresses gastric carcinogenesis through regulation of epigenetic alteration and cell cycle. Clin Cancer Res 2013; 19: 4599-4610.
50. Imam JS, Buddavarapu K, Lee-Chang JS, Ganapathy S, Camosy C, Chen Y et al. MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers. Oncogene 2010; 29: 4971-4979.
51. Akcakaya P, Ekelund S, Kolosenko I, Caramuta S, Ozata DM, Xie H et al. miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer. Int J Oncol 2011; 39: 311-318.